4.99

Verified by

0
Subscribe
Log in
Home ⋅ Press Release

Panaceayur Honored with Prestigious Award for Innovation in Ayurvedic Medicines

We are honored to announce that Dr. Arjun Kumar, Director of Panaceayur Multi-Specialty Ayurvedic Hospital, received the prestigious “Innovations in Ayurvedic Medicine” award at the Bangalore Business Excellence Awards 2024.

We are honored to announce that Dr. Arjun Kumar, Director of Panaceayur Multi-Specialty Ayurvedic Hospital, received the prestigious “Innovations in Ayurvedic Medicine” award at the Bangalore Business Excellence Awards 2024. The event, held at RG Royal Hotel in Bangalore and hosted by SwiftNLifè Media Group, celebrated outstanding achievements in business, healthcare, and innovation across India.

This award recognizes Dr. Kumar’s pioneering contributions to integrative antiviral therapy, where classical Ayurvedic formulations meet modern scientific validation—offering hope to patients suffering from chronic viral conditions like herpes, HIV, CMV, and EBV.

The event drew widespread media attention, with coverage in some of India’s most prominent platforms, including:

This recognition signifies the growing global shift toward holistic, root-cause-based healing systems—where ancient medical wisdom and 21st-century science work together for real, lasting results.

To learn more or explore the official press release network, visit  SwiftNLifè Events

Press Release Page
Read Full Bio

Panaceayur's Doctor

Panaceayur International Private Limited
Senior Doctor Writer at Panaceayur

Read this Next

Endocrine oncologist examining the neck of an adult patient with anaplastic thyroid cancer in a modern hospital.
Dabrafenib and Trametinib for BRAF V600E-Positive Anaplastic Thyroid Cancer
Learn how dabrafenib and trametinib are used for BRAF V600E-positive anaplastic thyroid cancer, including response rates, survival, tumour shrinkage, conversion from inoperable to operable disease, side effects, resistance, surgery, radiation, and what patients should discuss with their treatment team.
  • Read Next
Bookmark
BRAF V600E anaplastic thyroid cancer patient undergoing molecular testing and clinical evaluation in a modern oncology hospital.
BRAF V600E and Molecular Testing in Anaplastic Thyroid Cancer: A Patient Guide to Precision Treatment
BRAF V600E anaplastic thyroid cancer testing can reveal an important molecular treatment target and help guide precision treatment decisions. This comprehensive patient guide explains BRAF V600E, DNA and RNA molecular testing, NGS reports, targeted therapy, dabrafenib and trametinib, treatment resistance, BRAF-negative ATC, surgery after targeted therapy, liquid biopsy and carefully coordinated integrative supportive care.
  • Read Next
Bookmark
An oncology specialist examining a patient with anaplastic thyroid cancer and visible lower-neck swelling in a modern hospital.
Anaplastic Thyroid Cancer Stage IVA, IVB and IVC : Treatment, Operability and What Each Stage Means
Anaplastic thyroid cancer stages IVA, IVB and IVC describe how far the cancer has spread and strongly influence treatment decisions. Understand each stage, operability, targeted therapy, urgent warning signs, prognosis considerations, and the supportive role of Ayurveda in integrative care.
  • Read Next
Bookmark
Anaplastic thyroid cancer survival rate consultation between an oncologist and senior patient in a modern cancer hospital
Anaplastic Thyroid Cancer Survival Rate: Life Expectancy by Stage, Treatment and Individual Prognosis
Anaplastic thyroid cancer survival rate is not one fixed number. This patient-centred guide explains how stage, recurrence, BRAF V600E, treatment response, conditional survival, nutrition and functional strength shape prognosis, while helping patients identify the right questions and seek faster, personalised multidisciplinary care.
  • Read Next
Bookmark
Oncologist explaining the first 72 hours after an anaplastic thyroid cancer diagnosis to a patient and family member
First 72 Hours After an Anaplastic Thyroid Cancer Diagnosis: What Needs to Happen Now
Anaplastic thyroid cancer diagnosis requires fast, coordinated action. This patient-focused guide explains what should happen in the first 72 hours, including airway and swallowing assessment, expert pathology review, staging, BRAF testing, treatment planning and carefully coordinated Ayurveda support. It helps families ask the right questions, avoid dangerous delays and reach an experienced multidisciplinary team sooner.
  • Read Next
Bookmark
Close-up clinical view of lower-neck swelling in the thyroid region, illustrating inoperable anaplastic thyroid cancer.
Inoperable Anaplastic Thyroid Cancer: Is Recovery Possible With Ayurveda?
Inoperable anaplastic thyroid cancer does not always mean that every treatment path has ended. This patient-focused guide explains urgent breathing and swallowing concerns, molecular testing, non-surgical treatment possibilities and how personalised Ayurveda may support tumour-focused care, strength, digestion, nutrition and daily function. It also explains the potential role of Heeraka Bhasma, classical herbs, objective scan comparison and a complete report-based integrative case review.
  • Read Next
Bookmark